CD4 and myeloid sarcoma: Thus, the effects of curdlan injection on MS models seemed to be different, depending on several factors such as the etiology (autoimmune versus viral), disease onset (acute versus chronic disease), and effector mechanism (myelin-specific CD4+ T cells, anti-myelin antibodies, or anti-viral immune responses).